Company: STAA
Filing Date: 2025-12-08
Form Type: DFAN14A
Source: 0001213900-25-119309
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-12-08
Form: DFAN14A
Chunk 3
---
 believe the credibility and integrity of the transaction have been compromised by the previously non-competitive process. Furthermore, because the same board and executive management team oversaw both the original merger and the subsequent amendment and go-shop process, our concerns regarding objectivity and fairness remain the same.” 1

Neal C. Bradsher, Founder and President of Broadwood, said:

“The decision of Egan-Jones to reaffirm its recommendation that shareholders reject this deal, despite the Board’s last-ditch effort to save the transaction with a belated and perfunctory go-shop process, is both correct and a reflection of the deep skepticism observers and shareholders rightly have about this Board and transaction.

We have called for new directors, but the Board refused to adjust its composition to provide shareholders any basis for confidence in this new go-shop process. Instead, this latest process was, as Egan-Jones notes, overseen by the same directors, executives, bankers, and lawyers who designed and executed an inappropriate and flawed sale process in the first place. It is evident that the go-shop was never anything but a fig leaf, designed to give cover to a conflicted Board and produce only one predetermined outcome: a sale to Alcon at an inadequate price and with golden parachutes that richly reward STAAR’s executives.

It is for exactly these reasons that we are working to call a Special Meeting to remove from the Board the three incumbent directors – Chair Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee Chair Arthur Butcher – who we believe are most responsible for incentivizing, facilitating, and promoting the sale of the Company to Alcon at the wrong time, after a flawed process, and at an inadequate price. We continue to urge our fellow investors to vote ‘ AGAINST’this misbegotten deal.”

Shareholders can find additional information at www.LetSTAARShine.com.

| 1 | Permission                                 
 to use quotes neither sought nor obtained. |

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Special Meeting of Shareholders Originally Scheduled for October 23, 2025

Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”) are participants